
Real-time tumor margin detection with the aim to avoid reoperations and improve cancer care
One in three cancer surgeries require reoperation or additional treatment due to delayed margin assesment
Between 12 to 40% out of 600.000 EU/US breast cancer patients are confronted with reoperations and chemo/radio therapy
Reoperations and additional treatments put further pressure on already scarce resources, leading to increased waiting times
Healthcare insurance companies are faced with increased healthcare costs of ~300% for cancer surgeries
SPCTR delivers AI-powered, real time margin assessment to enable more informed cancer surgery
Our partners


